CHEK2 and breast cancer: Although we did not study the mechanisms by which the inhibition of the ATM:CHK2 pathway leads to a reduction in cell proliferation, the fact that the inhibition of ATR:CHK1 axis induces receptor degradation can account for the increased dependency of the ERα-positive BC cell lines to the ATR:CHK1 pathway inhibition.